A carregar...
Fidaxomicin for the Treatment of Clostridium Difficile Infection in the Pediatric Population - Not Quite So Soon Yet
Fidaxomicin is a new narrow spectrum macrocyclic antibiotic. It inhibits bacterial RNA polymerase and eradicates C difficile with minimal effect on normal intestinal flora. The US FDA granted orphan drug designation for all formulations of fidaxomicin for the treatment of C difficile infections in p...
Na minha lista:
| Publicado no: | Gastroenterology Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elmer Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139813/ https://ncbi.nlm.nih.gov/pubmed/27942322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4021/gr318e |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|